People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Black Iron Inc. | — | Other | Seed | $3.7M | $37.9M | 2011 |
| Lysoclear, Inc. | — | Pharmaceuticals | Seed | $3.0M | $114.1M | 2018 |
| Rodinia Lithium Inc. | — | Other | Pre-Seed | $235K | $5.4M | 2011 |
Aaron Wolfe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aaron Wolfe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stan Bharti | 2 | 14 |
| David Stein | 1 | 15 |
| Paul Bozoki | 1 | 5 |
| Pierre Pettigrew | 1 | 5 |
| Bruce Humphrey | 1 | 5 |
| Jennifer Wagner | 1 | 5 |
| Kelsey Moody | 1 | 4 |
| Ryan Ptolemy | 1 | 4 |
| FARHAD ABASOV | 1 | 4 |
| William Randall | 1 | 3 |
| David Porter | 1 | 3 |
| Tony Wonnacott | 1 | 3 |
| Roger Bagg | 1 | 2 |
| Mark Eaton | 1 | 2 |
| Matthew Simpson | 1 | 2 |
| John Detmold | 1 | 1 |
| Christine Gallo | 1 | 1 |
| Daniel Bruno | 1 | 1 |
| Christopher Westdal | 1 | 1 |
| Dave Porter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.